162 related articles for article (PubMed ID: 8376592)
1. Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism.
Di Minno G; Davì G; Margaglione M; Cirillo F; Grandone E; Ciabattoni G; Catalano I; Strisciuglio P; Andria G; Patrono C
J Clin Invest; 1993 Sep; 92(3):1400-6. PubMed ID: 8376592
[TBL] [Abstract][Full Text] [Related]
2. Platelet and monocyte variables in homocystinuria due to cystathionine-beta-synthase deficiency.
Coppola A; Albisinni R; Madonna P; Pagano A; Cerbone AM; Di Minno G
Haematologica; 1997; 82(2):189-90. PubMed ID: 9175326
[TBL] [Abstract][Full Text] [Related]
3. Increased thromboxane biosynthesis in essential thrombocythemia.
Rocca B; Ciabattoni G; Tartaglione R; Cortelazzo S; Barbui T; Patrono C; Landolfi R
Thromb Haemost; 1995 Nov; 74(5):1225-30. PubMed ID: 8607099
[TBL] [Abstract][Full Text] [Related]
4. Increased thromboxane metabolites excretion in liver cirrhosis.
Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
[TBL] [Abstract][Full Text] [Related]
5. In vivo platelet activation in homozygous cystathionine beta-synthase deficiency: a probucol-sensitive phenomenon.
Di Minno G; Margaglione M; Cirillo F; Grandone E; Davì G; Ciabattoni G; Catalano I; Strisciuglio P; Andria G; Coppola A
Trans Assoc Am Physicians; 1992; 105():149-56. PubMed ID: 1308991
[No Abstract] [Full Text] [Related]
6. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M
Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969
[TBL] [Abstract][Full Text] [Related]
8. Thromboxane biosynthesis and platelet function in type II diabetes mellitus.
Davì G; Catalano I; Averna M; Notarbartolo A; Strano A; Ciabattoni G; Patrono C
N Engl J Med; 1990 Jun; 322(25):1769-74. PubMed ID: 2345567
[TBL] [Abstract][Full Text] [Related]
9. Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo".
Landolfi R; De Candia E; Rocca B; Ciabattoni G; Antinori A; Masetti R; Patrono C
Thromb Haemost; 1994 Dec; 72(6):942-6. PubMed ID: 7740468
[TBL] [Abstract][Full Text] [Related]
10. Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus.
Ferro D; Basili S; Roccaforte S; Di Franco M; Cipollone F; Ciabattoni G; Davì G
Arthritis Rheum; 1999 Dec; 42(12):2689-97. PubMed ID: 10616019
[TBL] [Abstract][Full Text] [Related]
11. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group.
Davì G; Basili S; Vieri M; Cipollone F; Santarone S; Alessandri C; Gazzaniga P; Cordova C; Violi F
Am J Respir Crit Care Med; 1997 Dec; 156(6):1794-9. PubMed ID: 9412557
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation.
Martinuzzo ME; Maclouf J; Carreras LO; Lévy-Toledano S
Thromb Haemost; 1993 Oct; 70(4):667-71. PubMed ID: 8115993
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
[TBL] [Abstract][Full Text] [Related]
14. COX-2 is not involved in thromboxane biosynthesis by activated human platelets.
Patrignani P; Sciulli MG; Manarini S; Santini G; Cerletti C; Evangelista V
J Physiol Pharmacol; 1999 Dec; 50(4):661-7. PubMed ID: 10639016
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man.
Chiabrando C; Rivoltella L; Alberti E; Bonollo M; Djurup R; Fanelli R
Prostaglandins; 1993 May; 45(5):401-11. PubMed ID: 8321910
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine, coagulation, platelet function, and thrombosis.
Coppola A; Davi G; De Stefano V; Mancini FP; Cerbone AM; Di Minno G
Semin Thromb Hemost; 2000; 26(3):243-54. PubMed ID: 11011842
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P
Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573
[TBL] [Abstract][Full Text] [Related]
18. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
DeFilippis AP; Oloyede OS; Andrikopoulou E; Saenger AK; Palachuvattil JM; Fasoro YA; Guallar E; Blumenthal RS; Kickler TS; Jaffe AS; Gerstenblith G; Schulman SP; Rade JJ
Circ J; 2013; 77(11):2786-92. PubMed ID: 23985963
[TBL] [Abstract][Full Text] [Related]
20. Paired analysis of urinary thromboxane B2 metabolites in humans.
Catella F; FitzGerald GA
Thromb Res; 1987 Sep; 47(6):647-56. PubMed ID: 3686481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
